New Insights beyond Established Norms: A Scoping Review of Genetic Testing for Infertile Men
Urology Journal,
Vol. 21 No. 04 (2024),
9 Khordad 2024
,
Page 200-207
https://doi.org/10.22037/uj.v20i.8008
Abstract
Purpose : From a diagnostic standpoint, certain approaches to genetic screening in clinical practice remain ambiguous in the era of assisted reproduction. Even the most current guidelines do not provide definite guidance on testing protocols, leaving clinicians to carefully determine which tests best serve patients struggling with infertility. The lack of uniformity in the current practice of male fertility evaluation can prove to be quite costly, thus necessitating healthcare practitioners to carefully appraise the necessity and weigh the advantages against potential economic and psychological detriments. The objective of this review is to map the existing literature on the general topic of the clinical indications of routine karyotyping and/or AZF screening in infertile men, identify key concepts, determine where the gaps are, and lastly, provide an overview of the conclusions drawn from a body of knowledge that varies widely in terms of methodologies or disciplines.
Materials and Methods : A thorough search was conducted for the published findings up until July 2023, utilizing
PubMed (MEDLINE). This comprehensive search involved the use of specific search keywords, either individually
or in combination. The search terms employed were as follows: “Karyotype”, "Klinefelter" or "KS" or
"47,XXY", "AZF" or "Azoospermi*" and/or "microdeletion*" in the title or abstract. Once the titles and abstracts
of selected articles were obtained, the complete texts of linked papers were meticulously scrutinized.
Results : A total of 191 records were identified from PubMed. During screening, 161 records (84.3%) were eliminated. Finally, 30 papers were included in this scoping review, which was conducted in 18 countries. The number of sequence tag sites (STSs) used in the studies varied from 5 to 59. The rate of AZF deletions among patients with NOA ranged from 1.3% to 53%. The mean frequency was estimated to be 5.6%. The rate of YCM among patients with XXY karyotype was nil in 19 out of 30 studies (63%), whilst, in the remaining studies, the rate varied from 0.8% to 67%.
Conclusion : This review provides insights into managing male infertility. The presence of spermatozoa in ejaculation and successful surgical retrieval cannot be excluded for individuals with AZFb/AZFbc microdeletions.
Screening for Y chromosome microdeletions is not needed for mosaic or classic KS. Only 1% of individuals with
sperm concentration exceeding 1×106 sperm/mL and less than 5×106 sperm/mL exhibit AZF microdeletions; therefore, testing referral for such populations may need reassessment. Individuals with mosaic monosomy X karyotype and certain chromosomal anomalies should be referred for AZF deletion screening. These findings have implications for male infertility management and future research.
- Azoospermia
- AZF
- Karyotype
- Klinefelter syndrome
- Genetics
- Y chromosome microdeletions
- male infertility
How to Cite
References
Fakhro KA, Robay A, Rodriguez-Flores JL, Crystal RG. Genetic Evaluation of Male Infertility. In: Arafa M, Elbardisi H, Majzoub A, Agarwal A, eds. Genetics of Male Infertility: A Case-Based Guide for Clinicians: Springer Nature; 2020:95-118.
Krausz C, Riera-Escamilla A. Genetics of male infertility. Nat Rev Urol. 2018;15:369-84.
Nagirnaja L, Aston KI, Conrad DF. Genetic intersection of male infertility and cancer. Fertil Steril. 2018;109:20-6.
Colaco S, Modi D. Consequences of Y chromosome microdeletions beyond male infertility. J Assist Reprod Genet. 2019;36:1329-37.
Kuroda S, Usui K, Sanjo H, et al. Genetic disorders and male infertility. Reprod. Biomed. Online. 2020;19:314-22.
Vogt PH. Human chromosome deletions in Yq11, AZF candidate genes and male infertility: history and update. Mol Hum Reprod. 1998;4:739-44.
Grant MJ, Booth A. A typology of reviews: an analysis of 14 review types and associated methodologies. Health Info Libr J. 2009;26:91-108.
Tricco AC, Lillie E, Zarin W, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018;169:467-73.
Arksey H, O'Malley L. Scoping studies: towards a methodological framework. International journal of social research methodology. 2005;8:19-32.
Falagas ME, Pitsouni EI, Malietzis GA, Pappas G. Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses. FASEB J. 2008;22:338-42.
Pan S, Bearelly P, Oates RD. Fertility in men with Klinefelter syndrome and Y chromosome microdeletions: an update. Curr. Opin. Endocr. Metab. Res. 2019;6:21-8.
Simoni M, Bakker E, Eurlings M, et al. Laboratory guidelines for molecular diagnosis of Y-chromosomal microdeletions. Int. J. Androl. 1999;22:292-9.
Hadjkacem-Loukil L, Ghorbel M, Bahloul A, Ayadi H, Ammar-Keskes L. Genetic association between AZF region polymorphism and Klinefelter syndrome. Reprod. Biomed. Online. 2009;19:547-51.
Li LX, Dai HY, Ding XP, et al. Investigation of AZF microdeletions in patients with Klinefelter syndrome. Genet Mol Res. 2015;14:15140-7.
Ceylan C, Ceylan G, Serel T. The azoospermia factor locus-c region was found to be related to Klinefelter syndrome in Turkish patients. Genet Mol Res. 2010;9:1229-33.
Fu M, Chen M, Guo N, et al. Molecular genetic analysis of 1,980 cases of male infertility. Exp Ther Med. 2023;26:345.
Chen SW, Chen CP, Chern SR, Kuo YL, Chiu CL. The significance of karyotyping and azoospermia factor analysis in patients with nonobstructive azoospermia or oligozoospermia. Taiwan J Obstet Gynecol. 2022;61:800-5.
Sciarra F, Pelloni M, Faja F, et al. Incidence of Y chromosome microdeletions in patients with Klinefelter syndrome. J Endocrinol Invest. 2019;42:833-42.
Al-Achkar W, Wafa A, Moassass F. Cytogenetic abnormalities and Y-chromosome microdeletions in infertile Syrian males. Biomedical reports. 2013;1:275-9.
Simoni M, Tüttelmann F, Gromoll J, Nieschlag E. Clinical consequences of microdeletions of the Y chromosome: the extended Münster experience. Reprod. Biomed. Online. 2008;16:289-303.
Mitra A, Dada R, Kumar R, Gupta NP, Kucheria K, Gupta SK. Y chromosome microdeletions in azoospermic patients with Klinefelter's syndrome. Asian J Androl. 2006;8:81-8.
Peterlin B, Kunej T, Sinkovec J, Gligorievska N, Zorn B. Screening for Y chromosome microdeletions in 226 Slovenian subfertile men. Hum. Reprod. 2002;17:17-24.
Oliva R, Margarit E, Ballescá J-L, et al. Prevalence of Y chromosome microdeletions in oligospermic and azoospermic candidates for intracytoplasmic sperm injection. Fertil. Steril. 1998;70:506-10.
Zhang HG, Zhang ZB, Wang RX, et al. Male infertility in Northeast China: molecular detection of Y chromosome microdeletions in azoospermic patients with Klinefelter's syndrome. Genet Mol Res. 2013;12:4972-80.
Choe JH, Kim JW, Lee JS, Seo JT. Routine screening for classical azoospermia factor deletions of the Y chromosome in azoospermic patients with Klinefelter syndrome. Asian J Androl. 2007;9:815-20.
Kalantari H, Sabbaghian M, Vogiatzi P, et al. Bridging the Gap between AZF Microdeletions and Karyotype: Twelve Years' Experience of an Infertility Center. World J Mens Health. 2023;41:659-70.
Krausz C, Navarro-Costa P, Wilke M, Tüttelmann F. EAA/EMQN best practice guidelines for molecular diagnosis of Y-chromosomal microdeletions: State of the art 2023. Andrology. 2023.
Krausz C, Hoefsloot L, Simoni M, Tüttelmann F. EAA/EMQN best practice guidelines for molecular diagnosis of Y‐chromosomal microdeletions: state‐of‐the‐art 2013. Andrology. 2014;2:5-19.
Tüttelmann F, Gromoll J. Novel genetic aspects of Klinefelter's syndrome. Molecular Human Reproduction. 2010;16:386-95.
Gumus E, Kati B, Pelit ES, Ordek E, Ciftci H. A different look at genetic factors in individuals with non-obstructive azoospermia or oligospermia in our research study: To whom, which threshold, when, in what way? Rev Int Androl. 2021;19:41-8.
Özdemir TR, Özyılmaz B, Çakmak Ö, et al. Evaluation of chromosomal abnormalities and Y-chromosome microdeletions in 1696 Turkish cases with primary male infertility: A single-center study. Turk J Urol. 2020;46:95-100.
Abur U, Gunes S, Asci R, et al. Chromosomal and Y-chromosome microdeletion analysis in 1,300 infertile males and the fertility outcome of patients with AZFc microdeletions. Andrologia. 2019;51:e13402.
Akınsal EC, Baydilli N, Dündar M, Ekmekçioğlu O. The frequencies of Y chromosome microdeletions in infertile males. Turk. J. Urol. 2018;44:389.
Zhao P, Gu X, Wu H, Deng X. Molecular and cytogenetic analysis of infertile Hakka men with azoospermia and severe oligozoospermia in southern China. J Int Med Res. 2019;47:1114-23.
Kim SY, Lee BY, Oh AR, Park SY, Lee HS, Seo JT. Clinical, Hormonal, and Genetic Evaluation of Idiopathic Nonobstructive Azoospermia and Klinefelter Syndrome Patients. Cytogenet. Genome. Res. 2017;153:190-7.
Zhang YS, Dai RL, Wang RX, Zhang ZH, Fadlalla E, Liu RZ. Azoospermia factor microdeletions: occurrence in infertile men with azoospermia and severe oligozoospermia from China. Andrologia. 2014;46:535-40.
Behulova R, Varga I, Strhakova L, et al. Incidence of microdeletions in the AZF region of the Y chromosome in Slovak patients with azoospermia. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 2011;155.
Alkhalaf M, Al-Shoumer K. Cytogenetic abnormalities and azoospermia factor (AZF) microdeletions in infertile men from Kuwait. J. Mol. Genet. Med. 2010;4:232.
Malekasgar AM, Mombaini H. Screening of ‘Y’chromosome microdeletions in Iranian infertile males. J. Hum. Reprod. Sci. 2008;1:2.
Balkan M, Tekes S, Gedik A. Cytogenetic and Y chromosome microdeletion screening studies in infertile males with Oligozoospermia and Azoospermia in Southeast Turkey. J Assist Reprod Genet. 2008;25:559-65.
Hellani A, Al-Hassan S, Iqbal MA, Coskun S. Y chromosome microdeletions in infertile men with idiopathic oligo- or azoospermia. J Exp Clin Assist Reprod. 2006;3:1.
Dohle GR, Halley DJ, Van Hemel JO, et al. Genetic risk factors in infertile men with severe oligozoospermia and azoospermia. Hum Reprod. 2002;17:13-6.
Lee YH, Kim T, Kim MH, Kim YT, Kim SH. Y chromosome microdeletions in idiopathic azoospermia and non-mosaic type of Klinefelter syndrome. Exp. Mol. Med. 2000;32:231-4.
Tateno T, Sasagawa I, Ichiyanagi O, et al. Microdeletion of the DAZ (deleted in azoospermia) gene or the YRRM (Y chromosome ribonucleic acid recognition motif) gene does not occur in patients with Klinefelter's syndrome with and without spermatogenesis. Fertil. Steril. 1999;71:746-9.
Rucker GB, Mielnik A, KING P, GOLDSTEIN M, SCHLEGEL PN. Preoperative screening for genetic abnormalities in men with nonobstructive azoospermia before testicular sperm extraction. J. Urol. 1998;160:2068-71.
Krausz C, Rajpert-De Meyts E, Frydelund-Larsen L, Quintana-Murci L, McElreavey K, Skakkebaek NE. Double-blind Y chromosome microdeletion analysis in men with known sperm parameters and reproductive hormone profiles: microdeletions are specific for spermatogenic failure. J Clin Endocrinol Metab. 2001;86:2638-42.
Kohn TP, Kohn JR, Owen RC, Coward RM. The prevalence of Y-chromosome microdeletions in oligozoospermic men: a systematic review and meta-analysis of European and North American studies. European urology. 2019;76:626-36.
Omrani MD, Samadzadae S, Bagheri M, Attar K. Y chromosome microdeletions in idiopathic infertile men from West Azarbaijan. Urol. J. 2006;3:38-43.
Asadi F, Gilani MAS, Ghaheri A, Saffari JR, Zamanian M. The prevalence of Y chromosome microdeletions in Iranian infertile men with azoospermia and severe oligospermia. Cell J. 2017;19:27.
Patsalis PC, Skordis N, Sismani C, et al. Identification of high frequency of Y chromosome deletions in patients with sex chromosome mosaicism and correlation with the clinical phenotype and Y‐chromosome instability. Am. J. Med. Genet. A . 2005;135:145-9.
Patrat C, Bienvenu T, Janny L, et al. Clinical data and parenthood of 63 infertile and Y-microdeleted men. Fertil. Steril. 2010;93:822-32.
Patsalis PC, Sismani C, Quintana-Murci L, Taleb-Bekkouche F, Krausz C, McElreavey K. Effects of transmission of Y chromosome AZFc deletions. Lancet. 2002;360:1222-4.
Wyandt HE, Wilson GN, Tonk VS. Human chromosome variation: heteromorphism, polymorphism and pathogenesis: Springer; 2017.
Stouffs K, Vloeberghs V, Gheldof A, Tournaye H, Seneca S. Are AZFb deletions always incompatible with sperm production? Andrology. 2017;5:691-4.
Kleiman SE, Yogev L, Lehavi O, et al. The likelihood of finding mature sperm cells in men with AZFb or AZFb-c deletions: six new cases and a review of the literature (1994-2010). Fertil Steril. 2011;95:2005-12, 12 e1-4.
Vogt PH. AZF deletions and Y chromosomal haplogroups: history and update based on sequence. Hum Reprod Update. 2005;11:319-36.
Erzurumluoglu AM, Baird D, Richardson TG, Timpson NJ, Rodriguez S. Using Y-chromosomal haplogroups in genetic association studies and suggested implications. Genes. 2018;9:45.
Arredi B, Ferlin A, Speltra E, et al. Y-chromosome haplogroups and susceptibility to azoospermia factor c microdeletion in an Italian population. J Med Genet. 2007;44:205-8.
Grugni V, Battaglia V, Kashani BH, et al. Ancient migratory events in the Middle East: new clues from the Y-chromosome variation of modern Iranians. PloS one. 2012;7:e41252.
van Golde RJ, Wetzels AM, de Graaf R, Tuerlings JH, Braat DD, Kremer JA. Decreased fertilization rate and embryo quality after ICSI in oligozoospermic men with microdeletions in the azoospermia factor c region of the Y chromosome. Hum Reprod. 2001;16:289-92.
Sen S, Pasi AR, Dada R, Shamsi MB, Modi D. Y chromosome microdeletions in infertile men: prevalence, phenotypes and screening markers for the Indian population. J Assist Reprod Genet. 2013;30:413-22.
Castro A, Rodríguez F, Flórez M, et al. Pseudoautosomal abnormalities in terminal AZFb+c deletions are associated with isochromosomes Yp and may lead to abnormal growth and neuropsychiatric function. Hum Reprod. 2017;32:465-75.
- Abstract Viewed: 178 times
- 8008/pdf Downloaded: 29 times